<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Could FDA End Deadly Antibiotic Drug Trials?</title><link>http://articles.mercola.com/sites/articles/archive/2006/06/24/could-fda-end-deadly-antibiotic-drug-trials.aspx</link><description>The antibiotic drug Ketek, manufactured by Sanofi-Aventis, is being tested to treat ear infections and tonsillitis in close to 4,000 children, ages 6 months to 13 years. Although the Food and Drug Administration (FDA) approved plans for the trials, in</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>